Clinical trial

JUdicious Surveillance for Trastuzumab Induced Cardiotoxicity in the First Year

NCT06930521

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-22

PhaseNA

Study timeline

Study start (actual)2026-04-22Date precision: day

Registry last updated2026-06-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiovascular Healthunresolved

Breast Cancerunresolved

Breast Cancer Early Stage Breast Cancer (Stage 1-3)unresolved

Cardio-oncologyunresolved

Circulatory and Respiratory Healthunresolved

Clinical and Translational Cardiovascular Sciencesunresolved

Health Services and Systems - Healthcare Effectiveness &Amp; Outcomesunresolved

Interventions

Intervention - Low Risk Group OR Intermediate Risk GroupDIAGNOSTIC_TEST

Sponsors & collaborators

Women's College Hospitallead sponsor

University Health Network, Torontocollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06930521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.